Search

Displaying results 6491 - 6500 of 10000 in total
  1. Drug

    Ravuconazole

    go.drugbank.com/drugs/DB06440
    Investigational

  2. Drug

    Arverapamil

    go.drugbank.com/drugs/DB06669
    Investigational

  3. Drug

    Sotirimod

    go.drugbank.com/drugs/DB05680
    Experimental

  4. Drug

    Naronapride

    go.drugbank.com/drugs/DB05542
    Investigational

  5. Drug

    Casopitant

    go.drugbank.com/drugs/DB06634
    Investigational

  6. Drug

    Sus scrofa placenta

    go.drugbank.com/drugs/DB14243
    Investigational

    Sus scrofa placenta is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.

  7. Drug

    Pearl (hyriopsis cumingii)

    go.drugbank.com/drugs/DB14249
    Investigational

    Pearl (hyriopsis cumingii) is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.

  8. Drug

    Zansecimab

    go.drugbank.com/drugs/DB16389
    Investigational

    Zansecimab is under investigation in clinical trial NCT04342897 (A Study of LY3127804 in Participants With COVID-19).

  9. Drug

    Sitimagene ceradenovec

    go.drugbank.com/drugs/DB04907
    Experimental

    Sitimagene ceradenovec is a novel gene-based product for the treatment of patients with operable high grade glioma, a type of malignant brain tumour, given in addition to standard surgery and radiotherapy … It is being developed by Ark Therapeutics.

  10. Drug

    CYP-001

    go.drugbank.com/drugs/DB15739
    Investigational

    The MCA-derived MSCs can be obtained from induced pluripotent stem cells (iPSCs) and then expanded in media. … CYP-001 is a mesenchymoangioblast (MCA)-derived mesenchymal stem cell (MSC) therapy that originates from the mesoderm.